SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-078284
Filing Date
2022-03-17
Accepted
2022-03-17 16:02:15
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d303279d424b5.htm 424B5 329700
2 GRAPHIC g303279g04a37.jpg GRAPHIC 32281
3 GRAPHIC g303279g05b43.jpg GRAPHIC 133726
4 GRAPHIC g303279g06c59.jpg GRAPHIC 40261
  Complete submission text file 0001193125-22-078284.txt   603249
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-263370 | Film No.: 22748415
SIC: 2834 Pharmaceutical Preparations